ciglitazone has been researched along with Hyperglycemia, Postprandial in 7 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, DA | 1 |
| Goldstein, SW | 1 |
| Volkmann, RA | 1 |
| Eggler, JF | 1 |
| Holland, GF | 1 |
| Hulin, B | 1 |
| Stevenson, RW | 1 |
| Kreutter, DK | 1 |
| Gibbs, EM | 1 |
| Krupp, MN | 1 |
| Wrobel, J | 1 |
| Li, Z | 1 |
| Dietrich, A | 1 |
| McCaleb, M | 1 |
| Mihan, B | 1 |
| Sredy, J | 1 |
| Sullivan, D | 1 |
| Fujisawa, K | 1 |
| Nishikawa, T | 1 |
| Kukidome, D | 1 |
| Imoto, K | 1 |
| Yamashiro, T | 1 |
| Motoshima, H | 1 |
| Matsumura, T | 1 |
| Araki, E | 1 |
| Mishra, PK | 1 |
| Tyagi, N | 1 |
| Sen, U | 1 |
| Joshua, IG | 1 |
| Tyagi, SC | 1 |
| Yen, TT | 1 |
| Gill, AM | 1 |
| Powell, JG | 1 |
| Sampson, BM | 1 |
| Chang, AY | 1 |
| Wyse, BM | 2 |
| Diani, AR | 1 |
| Sawada, GA | 1 |
7 other studies available for ciglitazone and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
Topics: Adipose Tissue; Animals; Benzofurans; Biological Transport, Active; Cell Line; Deoxyglucose; Hypergl | 1991 |
Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
Topics: Animals; Blood Glucose; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Rats; Ra | 1998 |
TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis.
Topics: Cells, Cultured; DNA, Mitochondrial; Heat-Shock Proteins; Humans; Hyperglycemia; Hypoglycemic Agents | 2009 |
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
Topics: Animals; Antioxidants; Cardiomyopathies; Cyclic N-Oxides; Diabetes Complications; Diabetes Mellitus, | 2010 |
Ciglitazone prevents and reverses dexamethasone-induced hyperglycemia in female viable yellow mice.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Corticosterone; Dexamethasone; Dose-Respo | 1992 |
The hypoglycemic effect of ciglitazone in obese, hyperglycemic animal models.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Disease Models, Animal; Glycolysis; H | 1988 |
A review of the effects of ciglitazone on the pancreatic islets of obese, hyperglycemic mice.
Topics: Animals; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Mice; Mice, Obese; | 1988 |